tiprankstipranks
GenIP Plc (GB:GNIP)
LSE:GNIP
UK Market
Want to see GB:GNIP full AI Analyst Report?

GenIP Plc (GNIP) AI Stock Analysis

2 Followers

Top Page

GB:GNIP

GenIP Plc

(LSE:GNIP)

Select Model
Select Model
Select Model
Neutral 44 (OpenAI - 5.2)
Rating:44Neutral
Price Target:
5.00 p
▼(-51.22% Downside)
Action:N/A
Date:06/08/26
The score is held down primarily by heavy ongoing losses and negative free cash flow despite strong revenue growth, alongside weak technical trend signals with the stock trading below major moving averages. Balance-sheet leverage improved meaningfully with debt eliminated, but valuation support is limited due to the lack of usable P/E and dividend yield data.
Positive Factors
Revenue Growth
The large year-over-year revenue increase indicates accelerating market traction and product adoption. Sustained top-line growth over multiple periods would support operating leverage, provide scale to absorb fixed costs, and create a clearer path to profitability and durable cash generation if maintained.
Negative Factors
Persistent Losses
Despite revenue gains, the business continues to report substantial operating and net losses. Deep negative margins imply that without sustained margin recovery or far greater scale, profitability is unlikely, which will continue to erode equity and constrain strategic flexibility over the medium term.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Growth
The large year-over-year revenue increase indicates accelerating market traction and product adoption. Sustained top-line growth over multiple periods would support operating leverage, provide scale to absorb fixed costs, and create a clearer path to profitability and durable cash generation if maintained.
Read all positive factors

GenIP Plc (GNIP) vs. iShares MSCI United Kingdom ETF (EWC)

GenIP Plc Business Overview & Revenue Model

Company Description
GenIP Plc specializes in developing pioneering generative artificial intelligence solutions. The company was founded on February 23, 2024, and its primary operations are situated in London, United Kingdom....

GenIP Plc Financial Statement Overview

Summary
Revenue and gross margin improved materially in 2025, and the balance sheet strengthened with debt reduced to zero. However, results are still dominated by very large operating/net losses and persistently negative operating and free cash flow, while equity declined sharply year over year.
Income Statement
28
Negative
Balance Sheet
56
Neutral
Cash Flow
34
Negative
BreakdownTTMDec 2025Dec 2024
Income Statement
Total Revenue0.00520.39K123.02K
Gross Profit0.00164.74K15.16K
EBITDA-93.41K-1.06M-832.54K
Net Income-93.56K-1.25M-886.83K
Balance Sheet
Total Assets307.59K1.05M1.63M
Cash, Cash Equivalents and Short-Term Investments0.00660.99K972.36K
Total Debt72.14K0.00133.57K
Total Liabilities145.66K470.42K359.74K
Stockholders Equity161.93K579.16K1.27M
Cash Flow
Free Cash Flow-71.98K-736.00K-683.04K
Operating Cash Flow-69.91K-720.31K-556.74K
Investing Cash Flow-2.07K-6.07K-124.49K
Financing Cash Flow71.98K415.01K1.65M

GenIP Plc Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
62
Neutral
£70.24M18.8921.69%-19.19%-41.12%
61
Neutral
$37.18B12.37-10.20%1.83%8.50%-7.62%
55
Neutral
£470.38M-6.351.53%1.73%0.82%-1041.52%
54
Neutral
£36.04M12.588.83%2.44%-25.62%-20.46%
46
Neutral
£52.20M-5.44-25.90%-1.33%-38.06%
44
Neutral
£1.29M
* Technology Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
GB:GNIP
GenIP Plc
5.05
-21.95
-81.30%
GB:PULS
Access Intelligence
38.50
-1.50
-3.75%
GB:CLBS
Celebrus Technologies
94.50
-55.93
-37.18%
GB:GBG
GB Group plc
204.00
-62.13
-23.35%
GB:IGP
Intercede
116.75
-52.75
-31.12%

GenIP Plc Corporate Events

Regulatory Filings and Compliance
GenIP Updates Total Voting Rights and Share Capital Structure
Neutral
May 29, 2026
GenIP Plc has confirmed that its total issued share capital consists of 25,517,461 ordinary shares of £0.00425 each, all carrying voting rights, and that it holds no shares in treasury. This updated share capital figure provides investors wit...
Business Operations and StrategyFinancial DisclosuresPrivate Placements and Financing
GenIP posts rapid revenue growth as AI-driven innovation services scale globally
Positive
May 27, 2026
GenIP, which operates through its Invention Intelligence product suite and IP Commercialisation Services, provides AI-powered market intelligence reports and end-to-end innovation support to accelerate technology transfer and improve RD decision-m...
Business Operations and Strategy
GenIP lands new global university contracts as AI innovation tools gain traction
Positive
May 21, 2026
GenIP Plc has announced a series of new international orders for its AI-driven innovation evaluation services, expanding its footprint across Hong Kong, the U.K., South Africa, Canada, and the U.S. The company has signed a 12‑month framework...
Business Operations and StrategyFinancial DisclosuresPrivate Placements and Financing
GenIP raises £350,000 in discounted share placing to fund AI-led growth
Positive
May 1, 2026
GenIP Plc, an AIM-quoted AI-driven innovation consultancy, has raised £350,000 before expenses through a discounted placing of 5,000,000 new shares at 7p each, equivalent to roughly 24.4% of its existing share capital. The funding comes as th...
Business Operations and StrategyPrivate Placements and Financing
GenIP raises £350,000 in discounted share placing to fund AI-driven growth
Positive
May 1, 2026
GenIP Plc has raised £350,000 via a placing of 5,000,000 new shares at 7p, a 38% discount to the prior close, to fund staffing, research and development, and general working capital. The move, which increases its issued share capital to 25.5 ...
Business Operations and Strategy
GenIP Strikes Strategic U.S. Alliance With Cardinal IP to Drive AI-Led Growth
Positive
Apr 28, 2026
GenIP Plc has entered a strategic resale alliance with Cardinal Intellectual Property, creating a reciprocal arrangement under which each firm will sell the other’s services and combining GenIP’s AI-driven analytics platform with Cardi...
Business Operations and StrategyFinancial Disclosures
GenIP accelerates global AI-led innovation consultancy growth with Asia surge and expanded product suite
Positive
Mar 31, 2026
GenIP reported continued rapid commercial expansion in early 2026, following roughly 330% revenue growth in FY25, with strong order intake across the U.S., Asia and other key markets and renewal discussions under way with many FY25 clients. Asia h...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jun 08, 2026